Skip to main content
. 2019 Nov 27;11(1):156–165. doi: 10.1111/1759-7714.13258

Figure 5.

Figure 5

The expression of Axl, Gas6 and the sensitivity to gefitinib were compared in HCC827‐Gef‐Control, HCC827‐Gef‐miR‐34a, PC9‐Gef‐Control and PC9‐Gef‐miR‐34a cells. (a) The expression of Axl, Gas6 mRNA and protein in HCC827‐Gef‐Control and HCC827‐Gef‐miR‐34a cells by RT‐qPCR and western blot analysis. (Inline graphic) HCC827‐Gef‐Control and (Inline graphic) HCC827‐Gef‐miR‐34a. (b) The expression of Axl, Gas6 mRNA and protein in PC9‐Gef‐Control and PC9‐Gef‐miR‐34a cells by RT‐qPCR and western blot analysis. (Inline graphic) PC9‐Gef‐Control and (Inline graphic) PC9‐Gef‐miR‐34a. (c) The sensitivity of HCC827‐Gef‐Control and HCC827‐Gef‐miR‐34a cells to gefitinib was examined by CCK8 assay. (Inline graphic) HCC827‐Gef‐Control and (Inline graphic) HCC827‐Gef‐miR‐34a. (d) The sensitivity of PC9‐Gef‐Control and PC9‐Gef‐miR‐34a cells to gefitinib was examined by CCK8 assay. (Inline graphic) PC9‐Gef‐Control and (Inline graphic) PC9‐Gef‐miR‐34a.